Evaluation of Eating Behavior in Children with Psoriasis: Retrospective Cross Sectional Study

Background. Patients with psoriasis have increased thickness of visceral fat, including epicardial adipose tissue (EAT) that has wide spectrum of biological effects. Its thickness can be affected by the presence of obesity and eating behavior (EB) changes. Studying the associations between EB and markers of adipose tissue functional activity in children with psoriasis may help to better understand this variables correlations in the scope of comorbidities. Objective. Aim of the study is to analyze the relationship between Psoriasis Area and Severity Index (PASI), Children’s Dermatology Life Quality Index (CDLQI), EAT thickness, and leptin levels in pediatric patients with psoriasis and EB disorders. Methods. Retrospective cross sectional single-center study was conducted. 72 medical records of children with psoriasis (with varying body mass index level) who were examined and treated in dermatology department in the period from December 2021 to January 2024. All included patients have underwent dietician consultation and survey with DEBQ and CEBQ questionnaires, as a result predominant EB type was determined. EAT thickness (via two-dimensional echocardiography) and leptin levels were also measured. Psoriasis severity was evaluated via PASI and CDLQI indices. Patients were divided into three groups: with external, emotiogenic, and restrictive EB. The medians of the obtained values were calculated with determination of the confidence interval, all results were compared with each other via Kruskall-Wallis test. Results. Group of patients with external EB has shown following results: median EAT thickness was 2.5 mm (Q₁–Q₃: 2.1–2.8), median leptin level — 17.3 ng/ml (Q₁–Q₃: 14.4–26.4), median of PASI — 17 points (Q₁–Q₃: 12.5–20.5), median of CDLQI — 7 points (Q₁–Q₃: 4–13.5). Group of patients with emotionogenic EB has median EAT thickness of 2.2 mm (Q₁–Q₃: 1.85–2.55), median leptin level — 20.1 ng/ml (Q₁–Q₃: 14.5–23.95), median of PASI — 14 points (Q₁–Q₃: 12–16.5), median of CDLQI — 6 points (Q₁–Q₃: 3–12). Group of patients with restrictive EB has median EAT thickness of 3.4 mm (Q₁–Q₃: 3.1–3.9), median leptin level — 28.2 ng/ml (Q₁–Q₃: 26.1–33.5), median of PASI — 24 points (Q₁–Q₃: 21–27), median of CDLQI — 13 points (Q₁–Q₃: 9–21). Statistically significant (p = 0.0014) increase in PASI and CDLQI points was observed at comparison of different groups via Kruskall-Wallis test. Patients from restrictive EB group have shown higher values of EAT thickness, leptin levels, PASI, and CDLQI scores compared to patients with emotionogenic and external EB. No statistically significant differences were observed when comparing leptin levels and EAT thickness in the remaining groups. Conclusion. Patients with restrictive EB had higher PASI and CDLQI scores compared to patients with emotionogenic and external EB. No statistically significant differences were observed when comparing EAT thickness and leptin levels. Small study sample was the only research limitation.

1. Prevalence of Obesity. In: World Obesity Federation: Official website. Available online: https://www.worldobesity.org/about/about-obesity/prevalence-of-obesity. Accessed on October 08, 2024.

2. Thomas-Eapen N. Childhood Obesity. Prim Care. 2021;48(3): 505–515. doi: https://doi.org/10.1016/j.pop.2021.04.002

3. Drozdz D, Alvarez-Pitti J, Wójcik M, et al. Obesity and Cardiometabolic Risk Factors: From Childhood to Adulthood. Nutrients. 2021;13(11):4176. doi: https://doi.org/10.3390/nu13114176

4. Bronckers IM, Paller AS, van Geel MJ, et al. Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities. Paediatr Drugs. 2015;17(5):373–384. doi: https://doi.org/10.1007/s40272-015-0137-1

5. Yuditskaya TA. Rol’ i mesto narushenii pishchevogo povedeniya v kompleksnoi kharakteristike ozhireniya u detei. [abstract of dissertation]. Surgut; 2016. 188 p. (In Russ).

6. Mikhaylova AP, Shtrakhova AV. Eating Behavior in Norm, in Conditions of Stress and in the Presence of Pathology: Bibliographic Review. Bulletin of the South Ural State University. Ser. Psychology. 2018;11(3):80–95. (In Russ). doi: https://doi.org/10.14529/psy180310

7. Жунисова М.Б., Шалхарова Ж.С., Шалхарова Ж.Н. Типы пищевого поведения и абдоминальное ожирение // Медицина (Алматы). — 2015. — № 4. — С. 92–95

8. Schachter S, Rodin J. Obese humans and rats. (Psychology Revivals). 1st edn. Washington DC: Erlbaum/Halstead; 1974. 182 p.

9. Ozhirenie: etiologiya, patogenez, klinicheskie aspekty: Guide for doctors. Dedov II, Mel’nichenko GA,eds. Moscow: MIA; 2004. 456 p. (In Russ).

10. Silva JR. Restricción alimentaria y sobrealimentación: Un modelo de la neurociencia afectiva. Rev Med Chil. 2008;136(10):1336–1342.

11. Van Strien T, Herman CP, Verheijden MW. Eating style, overeating, and overweight in a representative Dutch sample. Does external eating play a role? Appetite. 2009;52(2):380–387. doi: https://doi.org/10.1016/j.appet.2008.11.010

12. O’Rahilly S, Farooqi S. Human obesity as a heritable disorder of the central control of energy balance. Int J Obes (Lond). 2008; 32(Suppl 7):S55–S61. doi: https://doi.org/10.1038/ijo.2008.239

13. Elks CE, den Hoed M, Zhao JH, et al. Variability in the heritability of body mass index: a systematic review and meta-regression. Front Endocrinol (Lausanne). 2012;3:29. doi: https://doi.org/10.3389/fendo.2012.00029

14. Nielsen LA, Bøjsøe C, Kloppenborg JT, et al. The influence of familial predisposition to cardiovascular complications upon childhood obesity treatment. PLoS One. 2015;10(3):0120177. doi: https://doi.org/10.1371/journal.pone.0120177

15. Solntseva AV, Sukalo A.V. Ozhirenie u detei. Voprosy etiologii i patogeneza. Meditsinskie novosti. 2008;(3):7–13. (In Russ).

16. Paller AS, Mercy K, Kwasny MJ, et al. Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study. JAMA Dermatol. 2013;149(2):166–176. doi: https://doi.org/10.1001/jamadermatol.2013.1078

17. Hunjan MK, Maradit Kremers H, Lohse C, Tollefson M. Association between obesity and pediatric psoriasis. Pediatr Dermatol. 2018;35(5):e304–e305. doi: https://doi.org/10.1111/pde.13539

18. Ambarchyan ET, Namazova-Baranova LS, Murashkin NN, et al. Leptin and Epicardial Fat: New Markers of Psoriasis in Children? Prospective Cross-Sectional Study. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2022;19(3):242–249. (In Russ). doi: https://doi.org/10.15690/pf.v19i3.2481

19. NamazovaBaranova LS, Ambarchyan ET, Ivanchikov VV, et al. Changes in Epicardial Fatty Tissue Thickness in Pediatric Patients with Psoriasis and on Biological Therapy: Prospective Cohort Study. Voprosy sovremennoi pediatrii — Current Pediatrics. 2023;22(5):406–414. (In Russ). doi: https://doi.org/10.15690/vsp.v22i5.2641

20. Altunay I, Demirci GT, Ates B, et al. Do eating disorders accompany metabolic syndrome in psoriasis patients? Results of a preliminary study. Clin Cosmet Investig Dermatol. 2011;4: 139–143. doi: https://doi.org/10.2147/CCID.S24165

21. Smith JD, Fu E, Kobayashi MA. Prevention and Management of Childhood Obesity and Its Psychological and Health Comorbidities. Annu Rev Clin Psychol. 2020;16:351–378. doi: https://doi.org/10.1146/annurev-clinpsy-100219-060201

22. Owczarczyk-Saczonek A, Placek W. Compounds of psoriasis with obesity and overweight. Postepy Hig Med Dosw (Online). 2017;71(1):761–772. doi: https://doi.org/10.5604/01.3001.0010.3854

23. Calderón García A, Alaminos-Torres A, Pedrero Tomé R, et al. Eating Behavior and Obesity in a Sample of Spanish Schoolchildren. Int J Environ Res Public Health. 2023;20(5):4186. doi: https://doi.org/10.3390/ijerph20054186

24. Tanofsky-Kraff M, Ranzenhofer LM, Yanovski SZ, et al. Psychometric properties of a new questionnaire to assess eating in the absence of hunger in children and adolescents. Appetite. 2008;51(1):148–155. doi: https://doi.org/10.1016/j.appet.2008.01.001

25. Gross AC, Fox CK, Rudser KD, et al. Eating behaviours are different in youth with obesity and severe obesity. Clin Obes. 2016;6(1):68–72. doi: https://doi.org/10.1111/cob.12127